ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neonatal Respiratory Distress Syndrome Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-0L13961
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Neonatal Respiratory Distress Syndrome Treatment Market Research Report 2023
BUY CHAPTERS

Global Neonatal Respiratory Distress Syndrome Treatment Market Research Report 2025

Code: QYRE-Auto-0L13961
Report
May 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Dragerwerk AG
GE Healthcare
Koninklijke Philips
Smiths Medical
Fisher & Paykel Healthcare
IBio Inc.
Windtree Therapeutics
Synthetic Biologics
Synairgen

Neonatal Respiratory Distress Syndrome Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neonatal Respiratory Distress Syndrome Treatment Market

Neonatal Respiratory Distress Syndrome Treatment Market

The global market for Neonatal Respiratory Distress Syndrome Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neonatal Respiratory Distress Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neonatal Respiratory Distress Syndrome Treatment.
The Neonatal Respiratory Distress Syndrome Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neonatal Respiratory Distress Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neonatal Respiratory Distress Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neonatal Respiratory Distress Syndrome Treatment Market Report

Report Metric Details
Report Name Neonatal Respiratory Distress Syndrome Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Home Care
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Dragerwerk, GE HealthCare, Koninklijke Philips, Smiths Medical, Fisher & Paykel Healthcare, IBIO, Windtree Therapeutics, Synthetic Biologics, Synairgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neonatal Respiratory Distress Syndrome Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neonatal Respiratory Distress Syndrome Treatment Market report?

Ans: The main players in the Neonatal Respiratory Distress Syndrome Treatment Market are Medtronic, Dragerwerk, GE HealthCare, Koninklijke Philips, Smiths Medical, Fisher & Paykel Healthcare, IBIO, Windtree Therapeutics, Synthetic Biologics, Synairgen

What are the Application segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment Market report?

Ans: The Applications covered in the Neonatal Respiratory Distress Syndrome Treatment Market report are Hospitals, Home Care, Others

What are the Type segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment Market report?

Ans: The Types covered in the Neonatal Respiratory Distress Syndrome Treatment Market report are Oxygen Therapy, Surfactant Therapy, Others

Recommended Reports

Neonatal & Pediatric Care

Respiratory Therapies

Lung & Heart Conditions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oxygen Therapy
1.2.3 Surfactant Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Home Care
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Perspective (2020-2031)
2.2 Global Neonatal Respiratory Distress Syndrome Treatment Growth Trends by Region
2.2.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neonatal Respiratory Distress Syndrome Treatment Historic Market Size by Region (2020-2025)
2.2.3 Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Region (2026-2031)
2.3 Neonatal Respiratory Distress Syndrome Treatment Market Dynamics
2.3.1 Neonatal Respiratory Distress Syndrome Treatment Industry Trends
2.3.2 Neonatal Respiratory Distress Syndrome Treatment Market Drivers
2.3.3 Neonatal Respiratory Distress Syndrome Treatment Market Challenges
2.3.4 Neonatal Respiratory Distress Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neonatal Respiratory Distress Syndrome Treatment Players by Revenue
3.1.1 Global Top Neonatal Respiratory Distress Syndrome Treatment Players by Revenue (2020-2025)
3.1.2 Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neonatal Respiratory Distress Syndrome Treatment Revenue
3.4 Global Neonatal Respiratory Distress Syndrome Treatment Market Concentration Ratio
3.4.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neonatal Respiratory Distress Syndrome Treatment Revenue in 2024
3.5 Global Key Players of Neonatal Respiratory Distress Syndrome Treatment Head office and Area Served
3.6 Global Key Players of Neonatal Respiratory Distress Syndrome Treatment, Product and Application
3.7 Global Key Players of Neonatal Respiratory Distress Syndrome Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neonatal Respiratory Distress Syndrome Treatment Breakdown Data by Type
4.1 Global Neonatal Respiratory Distress Syndrome Treatment Historic Market Size by Type (2020-2025)
4.2 Global Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Type (2026-2031)
5 Neonatal Respiratory Distress Syndrome Treatment Breakdown Data by Application
5.1 Global Neonatal Respiratory Distress Syndrome Treatment Historic Market Size by Application (2020-2025)
5.2 Global Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031)
6.2 North America Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025)
6.4 North America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031)
7.2 Europe Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025)
7.4 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031)
8.2 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031)
9.2 Latin America Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025)
9.4 Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size (2020-2031)
10.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Introduction
11.1.4 Medtronic Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Dragerwerk
11.2.1 Dragerwerk Company Details
11.2.2 Dragerwerk Business Overview
11.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Introduction
11.2.4 Dragerwerk Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.2.5 Dragerwerk Recent Development
11.3 GE HealthCare
11.3.1 GE HealthCare Company Details
11.3.2 GE HealthCare Business Overview
11.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Introduction
11.3.4 GE HealthCare Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.3.5 GE HealthCare Recent Development
11.4 Koninklijke Philips
11.4.1 Koninklijke Philips Company Details
11.4.2 Koninklijke Philips Business Overview
11.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Introduction
11.4.4 Koninklijke Philips Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.4.5 Koninklijke Philips Recent Development
11.5 Smiths Medical
11.5.1 Smiths Medical Company Details
11.5.2 Smiths Medical Business Overview
11.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Introduction
11.5.4 Smiths Medical Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.5.5 Smiths Medical Recent Development
11.6 Fisher & Paykel Healthcare
11.6.1 Fisher & Paykel Healthcare Company Details
11.6.2 Fisher & Paykel Healthcare Business Overview
11.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Introduction
11.6.4 Fisher & Paykel Healthcare Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.6.5 Fisher & Paykel Healthcare Recent Development
11.7 IBIO
11.7.1 IBIO Company Details
11.7.2 IBIO Business Overview
11.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Introduction
11.7.4 IBIO Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.7.5 IBIO Recent Development
11.8 Windtree Therapeutics
11.8.1 Windtree Therapeutics Company Details
11.8.2 Windtree Therapeutics Business Overview
11.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Introduction
11.8.4 Windtree Therapeutics Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.8.5 Windtree Therapeutics Recent Development
11.9 Synthetic Biologics
11.9.1 Synthetic Biologics Company Details
11.9.2 Synthetic Biologics Business Overview
11.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Introduction
11.9.4 Synthetic Biologics Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.9.5 Synthetic Biologics Recent Development
11.10 Synairgen
11.10.1 Synairgen Company Details
11.10.2 Synairgen Business Overview
11.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Introduction
11.10.4 Synairgen Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
11.10.5 Synairgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Dragerwerk AG
GE Healthcare
Koninklijke Philips
Smiths Medical
Fisher & Paykel Healthcare
IBio Inc.
Windtree Therapeutics
Synthetic Biologics
Synairgen
List of Tables
 Table 1. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oxygen Therapy
 Table 3. Key Players of Surfactant Therapy
 Table 4. Key Players of Others
 Table 5. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Region (2020-2025)
 Table 9. Global Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Region (2026-2031)
 Table 11. Neonatal Respiratory Distress Syndrome Treatment Market Trends
 Table 12. Neonatal Respiratory Distress Syndrome Treatment Market Drivers
 Table 13. Neonatal Respiratory Distress Syndrome Treatment Market Challenges
 Table 14. Neonatal Respiratory Distress Syndrome Treatment Market Restraints
 Table 15. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Neonatal Respiratory Distress Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Respiratory Distress Syndrome Treatment as of 2024)
 Table 18. Ranking of Global Top Neonatal Respiratory Distress Syndrome Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Neonatal Respiratory Distress Syndrome Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Neonatal Respiratory Distress Syndrome Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Neonatal Respiratory Distress Syndrome Treatment, Product and Application
 Table 22. Global Key Players of Neonatal Respiratory Distress Syndrome Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Neonatal Respiratory Distress Syndrome Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Medtronic Company Details
 Table 48. Medtronic Business Overview
 Table 49. Medtronic Neonatal Respiratory Distress Syndrome Treatment Product
 Table 50. Medtronic Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 51. Medtronic Recent Development
 Table 52. Dragerwerk Company Details
 Table 53. Dragerwerk Business Overview
 Table 54. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product
 Table 55. Dragerwerk Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 56. Dragerwerk Recent Development
 Table 57. GE HealthCare Company Details
 Table 58. GE HealthCare Business Overview
 Table 59. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product
 Table 60. GE HealthCare Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 61. GE HealthCare Recent Development
 Table 62. Koninklijke Philips Company Details
 Table 63. Koninklijke Philips Business Overview
 Table 64. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product
 Table 65. Koninklijke Philips Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 66. Koninklijke Philips Recent Development
 Table 67. Smiths Medical Company Details
 Table 68. Smiths Medical Business Overview
 Table 69. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product
 Table 70. Smiths Medical Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 71. Smiths Medical Recent Development
 Table 72. Fisher & Paykel Healthcare Company Details
 Table 73. Fisher & Paykel Healthcare Business Overview
 Table 74. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product
 Table 75. Fisher & Paykel Healthcare Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 76. Fisher & Paykel Healthcare Recent Development
 Table 77. IBIO Company Details
 Table 78. IBIO Business Overview
 Table 79. IBIO Neonatal Respiratory Distress Syndrome Treatment Product
 Table 80. IBIO Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 81. IBIO Recent Development
 Table 82. Windtree Therapeutics Company Details
 Table 83. Windtree Therapeutics Business Overview
 Table 84. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product
 Table 85. Windtree Therapeutics Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 86. Windtree Therapeutics Recent Development
 Table 87. Synthetic Biologics Company Details
 Table 88. Synthetic Biologics Business Overview
 Table 89. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product
 Table 90. Synthetic Biologics Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 91. Synthetic Biologics Recent Development
 Table 92. Synairgen Company Details
 Table 93. Synairgen Business Overview
 Table 94. Synairgen Neonatal Respiratory Distress Syndrome Treatment Product
 Table 95. Synairgen Revenue in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 96. Synairgen Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Neonatal Respiratory Distress Syndrome Treatment Picture
 Figure 2. Global Neonatal Respiratory Distress Syndrome Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Oxygen Therapy Features
 Figure 5. Surfactant Therapy Features
 Figure 6. Others Features
 Figure 7. Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Home Care Case Studies
 Figure 11. Others Case Studies
 Figure 12. Neonatal Respiratory Distress Syndrome Treatment Report Years Considered
 Figure 13. Global Neonatal Respiratory Distress Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Neonatal Respiratory Distress Syndrome Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Neonatal Respiratory Distress Syndrome Treatment Market Share by Players in 2024
 Figure 17. Global Top Neonatal Respiratory Distress Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Respiratory Distress Syndrome Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Neonatal Respiratory Distress Syndrome Treatment Revenue in 2024
 Figure 19. North America Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Neonatal Respiratory Distress Syndrome Treatment Market Share by Country (2020-2031)
 Figure 21. United States Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Neonatal Respiratory Distress Syndrome Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Share by Region (2020-2031)
 Figure 33. China Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Neonatal Respiratory Distress Syndrome Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Neonatal Respiratory Distress Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Medtronic Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 49. Dragerwerk Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 50. GE HealthCare Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 51. Koninklijke Philips Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 52. Smiths Medical Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 53. Fisher & Paykel Healthcare Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 54. IBIO Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 55. Windtree Therapeutics Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 56. Synthetic Biologics Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 57. Synairgen Revenue Growth Rate in Neonatal Respiratory Distress Syndrome Treatment Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bronchopulmonary Dysplasia Drug Market Research Report 2024
Swine Respiratory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neonatal Intensive Care Respiratory Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Upper Respiratory Tract Disorder Diagnostics and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heart and Lung Therapy System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Viral Pneumonia Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infant and Baby Cold Medicine Market Research Report 2025
Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amniotic Membrane Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiation Pneumonitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multisystem Inflammatory Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nesiritide Drug Market Research Report 2024
Global Retinopathy Of Prematurity Therapeutics Market Research Report 2024
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Q5936
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Acute Intermittent Porphyria Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6U7336
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Phenylketonuria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12R6229
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions